These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29867734)

  • 1. Suboptimal Baseline Serum Vitamin B12 Is Associated With Cognitive Decline in People With Alzheimer's Disease Undergoing Cholinesterase Inhibitor Treatment.
    Cho HS; Huang LK; Lee YT; Chan L; Hong CT
    Front Neurol; 2018; 9():325. PubMed ID: 29867734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid with or without vitamin B12 for cognition and dementia.
    Malouf M; Grimley EJ; Areosa SA
    Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Neuropsychological Outcome in Taiwanese Alzheimer's Disease Patients Treated with Medication.
    Yang YH; Wu MN; Chou PS; Su HC; Lin SH; Sung PS
    Curr Alzheimer Res; 2018 Mar; 15(5):474-481. PubMed ID: 29032750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deep cerebral microbleeds are associated with poor cholinesterase inhibitor treatment response in people with Alzheimer disease.
    Chiu WT; Lee TY; Chan L; Wu D; Huang LK; Chen DY; Lee YT; Hu CJ; Hong CT
    Clin Neurol Neurosurg; 2020 Aug; 195():105959. PubMed ID: 32480198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in cognitive function according to cholinesterase inhibitor use and amyloid PET positivity in patients with mild cognitive impairment.
    Pyun JM; Ryoo N; Park YH; Kim S
    Alzheimers Res Ther; 2021 Jan; 13(1):10. PubMed ID: 33402198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mild versus moderate stages of Alzheimer's disease: three-year outcomes in a routine clinical setting of cholinesterase inhibitor therapy.
    Wattmo C; Minthon L; Wallin ÅK
    Alzheimers Res Ther; 2016 Feb; 8():7. PubMed ID: 26883213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
    Wattmo C; Wallin ÅK
    Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized placebo controlled trial of vitamin B
    Kwok T; Lee J; Ma RC; Wong SY; Kung K; Lam A; Ho CS; Lee V; Harrison J; Lam L
    Clin Nutr; 2017 Dec; 36(6):1509-1515. PubMed ID: 27823800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
    Malouf R; Grimley Evans J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004514. PubMed ID: 18843658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial cognitive response to cholinesterase inhibitors and subsequent long-term course in patients with mild Alzheimer's disease.
    Droogsma E; van Asselt D; Diekhuis M; Veeger N; van der Hooft C; De Deyn PP
    Int Psychogeriatr; 2015 Aug; 27(8):1323-33. PubMed ID: 25779465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Nootropics in Combination with Cholinesterase Inhibitors on Cognitive Function in Mild-to-Moderate Dementia: A Study Using Real-World Data.
    Kang M; Lee DB; Kwon S; Lee E; Kim WJ
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender Differences in Neuropsychiatric Symptoms in Mild to Moderate Alzheimer's Disease Patients Undergoing Switch of Cholinesterase Inhibitors: A Post Hoc Analysis of the EVOLUTION Study.
    Colombo D; Caltagirone C; Padovani A; Sorbi S; Spalletta G; Simoni L; Ori A; Zagni E
    J Womens Health (Larchmt); 2018 Nov; 27(11):1368-1377. PubMed ID: 30085899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin B12 deficiency: Characterization of psychometrics and MRI morphometrics.
    Hsu YH; Huang CF; Lo CP; Wang TL; Tu MC
    Nutr Neurosci; 2016; 19(2):47-54. PubMed ID: 26339714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Borderline Levels of Serum Vitamin B12 May Predict Cognitive Decline in Elderly Hip Fracture Patients.
    Mizrahi EH; Lubart E; Leibovitz A
    Isr Med Assoc J; 2017 May; 19(5):305-308. PubMed ID: 28513119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Vitamin B12 Levels: An Underestimated Cause Of Minimal Cognitive Impairment And Dementia.
    Jatoi S; Hafeez A; Riaz SU; Ali A; Ghauri MI; Zehra M
    Cureus; 2020 Feb; 12(2):e6976. PubMed ID: 32206454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Vitamin B12 levels and cognitive function in the elderly Korean population.
    Soh Y; Lee DH; Won CW
    Medicine (Baltimore); 2020 Jul; 99(30):e21371. PubMed ID: 32791746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Vitamin B12 deficiency in elderly population (>60 years) presenting with dementia to outpatient department.
    Sashindran VK; Aggarwal V; Khera A
    Med J Armed Forces India; 2022 Jan; 78(1):94-98. PubMed ID: 35035050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term Effects of Cholinesterase Inhibitors on Cognitive Decline and Mortality.
    Xu H; Garcia-Ptacek S; Jönsson L; Wimo A; Nordström P; Eriksdotter M
    Neurology; 2021 Apr; 96(17):e2220-e2230. PubMed ID: 33741639
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.